Post-Cardiac Surgery Bleeding Management (EACTS 2024)
Post-Cardiac Surgery Bleeding Management (EACTS 2024): Post-Cardiac Surgery Bleeding → Assess Bleeding Severity → ⚠️ MASSIVE BLEEDING → Return to OR → B...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Post-Cardiac Surgery Bleeding
Elevated chest tube output or hemodynamic instability in post-op period
- ◆Decision
Assess Bleeding Severity
Quantify chest tube output and clinical status
- Measure chest tube output hourly
- Trend hemoglobin/hematocrit
- Assess hemodynamic stability
- Check for signs of tamponade
- ⚠Warning
⚠️ MASSIVE BLEEDING
>400 mL/hr or hemodynamic collapse
- Activate massive transfusion protocol
- Prepare for immediate re-exploration
- Call cardiac surgery STAT
- ●Action
Return to OR
Surgical re-exploration
- Median sternotomy re-opening
- Evacuate clot
- Identify and control surgical bleeding
- Irrigate and reclose
- Continue hemostatic resuscitation
- ✓Outcome
Bleeding Controlled
Continue routine post-op care
- ⚠Warning
⚠️ Rule Out Tamponade
Sudden drop in chest tube output + hypotension = assume tamponade until proven otherwise
- ●Action
Significant Bleeding
>200 mL/hr for 2+ hours
- Check chest tubes for patency - milk gently
- Warm patient to 37°C
- Correct acidosis
- Obtain coagulation labs + viscoelastic test
- ●Action
Coagulation Assessment
Use viscoelastic testing if available
- TEG or ROTEM preferred over conventional tests
- Check: PT/INR, aPTT, fibrinogen, platelets
- Consider heparin rebound (protamine re-dose)
- Assess platelet function if on antiplatelet agents
- ●Action
Correct Coagulopathy
Guided by TEG/ROTEM or conventional labs
- Fibrinogen <1.5 g/L: Fibrinogen concentrate or cryoprecipitate
- Platelets <100 × 10⁹/L: Platelet transfusion
- INR >1.5: PCC or FFP (PCC preferred)
- Heparin rebound: Protamine 25-50 mg
- Consider desmopressin (DDAVP) 0.3 mcg/kg
- Tranexamic acid if ongoing fibrinolysis
- ◆Decision
Re-exploration Indicated?
Assess need for surgical intervention
- Indications for re-exploration:
- • >400 mL in first hour
- • >200 mL/hr for 4 hours despite correction
- • Sudden cessation of drainage (clot)
- • Hemodynamic instability
- • Signs of tamponade
- ●Action
Continue Medical Management
If bleeding controlled with correction
- Serial hemoglobin monitoring (q2-4h)
- Continue warming
- Maintain Hb >7-8 g/dL (>8-9 if ongoing bleeding)
- Watch for delayed tamponade
- ●Action
Transfusion Targets
Restrictive approach when stable
- Hemoglobin trigger: 7-8 g/dL (stable)
- Higher threshold if active bleeding/ischemia
- Avoid over-transfusion (increased complications)
- Use cell salvage when available
- ●Action
Moderate Bleeding
100-200 mL/hr
- Monitor closely
- Check coagulation status
- Optimize temperature and pH
- Review anticoagulation status
Guideline Source
EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery 2024
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Thresholds may vary by institution
- Requires access to viscoelastic testing (TEG/ROTEM) for optimal management
- Does not address pediatric cardiac surgery
- Anticoagulation management in specific valve types requires specialist input
Applicable Regions
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Post-Cardiac Surgery Bleeding Management (EACTS 2024)?
The Post-Cardiac Surgery Bleeding Management (EACTS 2024) is a emergency clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery 2024.
What guideline is the Post-Cardiac Surgery Bleeding Management (EACTS 2024) based on?
This algorithm is based on EACTS/EACTAIC Guidelines on Patient Blood Management in Adult Cardiac Surgery 2024 (DOI: 10.1093/ejcts/ezae352).
What are the limitations of the Post-Cardiac Surgery Bleeding Management (EACTS 2024)?
Known limitations include: Thresholds may vary by institution; Requires access to viscoelastic testing (TEG/ROTEM) for optimal management; Does not address pediatric cardiac surgery; Anticoagulation management in specific valve types requires specialist input. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Post-Cardiac Surgery Bleeding Management (EACTS 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free